SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NERVGEN PHARMA CORP files

Nervgen Pharma Corp submits filing to SEC. Filing details not specified.

NGEN

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.